The MHRA approved tirzepatide following clinical trials demonstrating superior glycaemic control and weight loss compared to other GLP-1 receptor agonists
This finding is particularly significant given that some trials extended to 24 weeks of continuous exposure and included individuals with obesity-related health conditions who might have higher baseline health risks
Neuromodulatory effects of anti-diabetes medications: a mechanistic review
So we advise pregnant women to check with their healthcare provider before adding astaxanthin to their diet in any meaningful amount
It also notes that as GLP-1 therapy drives weight loss, thyroid hormone requirements may change, and that any change should follow TSH trends rather than weight alone
Truncation studies showed that the membrane proximal 61 amino acids of GP130 are sufficient for signal transduction (68), and later it was shown for GHR that the membrane proximal 20 residues (which includes the Box1 motif) of the ICD is sufficient for JAK2 binding, but not sufficient for GH-induced activation of JAK2 (69)
